Active ingredientDenaverineCat. No. P-D045-001CAS 3579-62-2Family · Pharmaceutical analytical standards
Denaverine
An antispasmodic that, like papaverine, inhibits phosphodiesterases and also has anticholinergic effects. Developed in Germany and patented in 1974, it has been used in humans for urogenital and gastrointestinal spasms. This family brings together the active ingredient and other impurities.
Did you know?It is also used in veterinary medicine: it relaxes the uterine muscle of cows and dogs during birth.
Go to the active ingredient →Active ingredientDenaverineCat. No. P-D045-001CAS 3579-62-2
Active ingredientDenaverine HClCat. No. P-D045-002CAS 3321-06-0
Impurity2-(Dedimethyldeamino)deethyl DenaverineCat. No. P-D045-003CAS 2594-45-8
ImpurityDenaverine Impurity 1Cat. No. P-D045-004
ImpurityDenaverine Impurity 2Cat. No. P-D045-005CAS 56723-50-3
ImpurityDenaverine Impurity 3 HydrochlorideCat. No. P-D045-006CAS 4348-15-6No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.